Hyun-Soo Lee
Director/Board Member bei APROGEN MEDICINES INC.
Profil
Hyun-Soo Lee is currently an Independent Director at Aprogen, Inc., a Director at Pharosvaccine, and a Professor at Seoul National University.
He is also a Member of The National Academy of Engineering of Korea and was the President of the Korea Association of Procurement & Supply Management.
Previously, he held positions such as Independent Director at Samsung C&T Corp., Chief Operating Officer & Executive Vice President at Samyang Genex Corp., and President-New Business Development at Celltrion, Inc. He was also the President of the Architectural Institute of Korea, Korea Facility Management Association, and Korea Institute of Construction Engineering & Management.
Dr. Lee holds a doctorate degree from the University of Michigan and undergraduate and graduate degrees from Seoul National University.
Aktive Positionen von Hyun-Soo Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| APROGEN MEDICINES INC. | Director/Board Member | - |
| Seoul National University | Corporate Officer/Principal | - |
| The National Academy of Engineering of Korea | Corporate Officer/Principal | 01.01.2012 |
| Korea Association of Procurement & Supply Management | President | 01.01.2011 |
| Pharosvaccine | Director/Board Member | - |
Ehemalige bekannte Positionen von Hyun-Soo Lee
| Unternehmen | Position | Ende |
|---|---|---|
| Architectural Institute of Korea | President | 01.01.2020 |
| Korea Facility Management Association | President | 01.01.2010 |
| Korea Institute of Construction Engineering & Management | President | 01.01.2009 |
Celltrion, Inc. /Old/
 Celltrion, Inc. /Old/ BiotechnologyHealth Technology Celltrion, Inc. manufactures biomedical and pharmaceutical products. It manufactures therapeutic monoclonal antibodies and recombinant proteins. The company was founded in 2002 and is headquartered in Inchon, South Korea. | Corporate Officer/Principal | 02.09.2008 |
| ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Hyun-Soo Lee
| University of Michigan | Doctorate Degree |
| Seoul National University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| APROGEN MEDICINES INC. | Health Technology |
| SAMSUNG C&T CORPORATION | Industrial Services |
| Private Unternehmen | 9 |
|---|---|
Samyang Genex Corp.
 Samyang Genex Corp. Agricultural Commodities/MillingProcess Industries Samyang Genex Corp. engages in the manufacture of starches and glucose or maltose. Its products include glucose, starch syrup, fructose, general starch, modified starch, sorbitol, maltitol, and oligosaccharides. The company was founded on April 3, 1964 and is headquartered in Seoul, South Korea. | Process Industries |
Celltrion, Inc. /Old/
Celltrion, Inc. /Old/ BiotechnologyHealth Technology Celltrion, Inc. manufactures biomedical and pharmaceutical products. It manufactures therapeutic monoclonal antibodies and recombinant proteins. The company was founded in 2002 and is headquartered in Inchon, South Korea. | Health Technology |
Aprogen, Inc. /Old/
 Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| The National Academy of Engineering of Korea | |
| Architectural Institute of Korea | |
| Korea Association of Procurement & Supply Management | |
| Korea Facility Management Association | |
| Korea Institute of Construction Engineering & Management | |
| Pharosvaccine |
